Stay updated on Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial
Sign up to get notified when there's something new on the Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial page.

Latest updates to the Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial page
- CheckyesterdayChange DetectedThe displayed app/page revision version has been updated from v3.5.2 to v3.5.3, indicating a backend/UI release rather than a change to the clinical trial details.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Naples, Italy and removed Napoli, Italy in the Italy locations to reflect the current site listings with English city names.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded Hepatocellular carcinoma and a new Genetic and Rare Diseases Information Center resource; updated the page revision to v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

- Check44 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded Revision: v3.4.2. Removed the previous funding/operating status notice and Revision: v3.4.1 text.SummaryDifference0.2%

Stay in the know with updates to Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial page.